BETHESDA, Maryland (The Adobo Chronicles, Washington Bureau) – It was in March of 2014 when we first reported that the American Psychiatric Association (APA) officially classified the taking of selfies as a mental disorder.
The disease was given the namer ‘selfitis.’ It was reaching an epidemic proportion.
Other than self-control methods and cognitive behavioral therapy (CBT), the World Health Organization and the U.S. Food and Drug Administration (FDA) have not approved a cure since then.
Today, however, the FDA announced that it has approved and licensed a new pill that counters the urge to take a selfie. It was developed by Bayer, the same company that markets aspirin.
Recommended dosage is 1 tablet per day for men, and 5 tablets per day for women.
Bayer explained that the higher dosage for women was because in clinical trials conducted throughout the country, women had a more difficult time resisting the urge to take a selfie.
The downside to the new anti-selfie tablet is that it has to be taken for life.